CD274 and cancer: Wuet al. [48] reported that USP9X in oral squamous cell carcinoma could induce the deubiquitination of PD-L1, reduce the polyubiquitination of PD-L1 and stabilize its structure, prompting cancer cells to undergo immune escape.